Stock Code: 6645 Company Name: GeneFirst-Emerging Industry: Biotechnology and Medical Care Data Month: 2026-02 Monthly Revenue: NT$35,863 thousand (NT$36 million) Year-over-Year Change: +12.0%
FACT BOX
- Source: PR Times
- Category: 其他
其他
[GeneFirst-Emerging] February 2026 Revenue: NT$36 Million (YoY +12.0%)
Citation-Grade
Primary-source linked
Schema.org verified
NQ 50 / 100
Published Feb 1, 2026 9:00 AM ・ Updated Jun 1, 2026 12:17 PM ・ 2 min read ・ Source: PR Times
Show contents
⚡ Key Points
- GeneFirst-Emerging announced its revenue for February 2026 reached NT$36 million, a 12.0% increase year-over-year.
- The revenue figures for the biotechnology company, which specializes in precision medicine, demonstrate stable growth in its genetic testing services business.
GeneFirst-Emerging announced its revenue for February 2026 reached NT$36 million, a 12.0% increase year-over-year. The revenue figures for the biotechnology company, which specializes in precision medicine, demonstrate stable growth in its genetic testing services business.
Editorial & Verification Standards
The Washin AI News desk structures and reviews this article under the following standards.
- Start only from primary sources (official PR, disclosures, wire services)
- Numbers and proper nouns machine-checked against the source (number-completeness check)
- Company names and tickers verified via registry (Registry/TWSE/Wikidata)
- No speculation; nothing stated that is not in the source
Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›
- Announced Feb 1, 2026 9:00 AM — Distributor PR Times
- Collected Apr 7, 2026 8:00 AM
- AI structured & analyzed Apr 8, 2026 12:19 AM
- Desk-reviewed & published Feb 1, 2026 9:00 AM
FAQ
What are the key facts in this article?
GeneFirst-Emerging announced its revenue for February 2026 reached NT$36 million, a 12.0% increase year-over-year. The revenue figures for the biotechnology company, which specializes in precision medicine, demonstrate stable growth in its genetic testing services business.
Where is the primary source?
PR Times: https://openapi.twse.com.tw/revenue/twse-rev-6645-11502
When was it published?
Feb 1, 2026
Cite this article — HOW TO CITE
Washin AI News Desk“[GeneFirst-Emerging] February 2026 Revenue: NT$36 Million (YoY +12.0%)”AI News by Washin Village（和心村）, Feb 1, 2026. https://aeo.washinmura.jp/ai/%E9%87%91%E8%90%AC%E6%9E%97-%E5%89%B5/en/news/2026-02-01-genefirst-emerging-february-2026-revenue
AI CRAWLER ACTIVITY
as of Jul 17, 2026
AI crawler visits to this article (cumulative)122 bots
Site-wide cumulative
Applebot
bot_visits_summary
4127k
last Jul 17, 2026
ClaudeBot
bot_visits_summary
3016k
last Jul 17, 2026
GPTBot
bot_visits_summary
2581k
last Jul 17, 2026
Bingbot
bot_visits_summary
2448k
last Jul 17, 2026
Meta AI
bot_visits_summary
1010k
last Jul 17, 2026
Google AI
bot_visits_summary
687k
last Jul 17, 2026
※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.
Washin AI News（AI News by Washin Village（和心村））
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.
Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification
Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →